Isotretinoin Often Continued Despite Mood Concerns
Despite early psychological symptoms, over half of patients in the study completed their full treatment course.
Related Articles
Perspective in Rheumatic Diseases
We know that connecting with colleagues is essential. Meet new colleagues and catch up with everyone in your professional circle. Join us for the 2024…
Perspective in Rheumatic Diseases
We know that connecting with colleagues is essential. Meet new colleagues and catch up with everyone in your professional circle. Join us for the 2024…
Dual-Energy Approach Boosts Skin Hydration
Dual-energy RF and TUS technology significantly enhances HA production, promoting skin rejuvenation by activating fibroblasts in the reticular dermis. Clinical study results showed a 67.69%…
Using Real-World AD Cases to Pick the Right Therapy for Each Patient
In a recent Dermatology Times Case-Based Peer Perspectives custom video series, Naiem Issa, MD, PhD, reviewed 3 complex patient cases of atopic dermatitis.
Live from #AACE2025: Symposia on Endocrinology
Thursday, May 15, 2025 & Friday, May 16, 2025 Medscape is pleased to present live symposia in Orlando at #AACE2025 in May 2025. Each event…
Study Identifies Unidirectional Link Between Primary Biliary Cirrhosis and Psoriasis Risk
Is there a causal relationship between primary biliary cirrhosis and psoriasis?
Acne Conglobata and Bimekizumab
This case report describes 2 patients who received off-label bimekizumab for treatment-resistent acne conglobata.
FDA Places Clinical Hold on VYNE’s VYN202 Phase 1b Trial for Plaque Psoriasis
VYNE Therapeutics paused its VYN202 trial for psoriasis due to an FDA-issued clinical hold.
Redefining Anti-Aging with Regenerative Aesthetics and Growth Factor Skincare
Prithwiraj Maitra, PhD, Vice President of Global Skincare R&D at Allergan Aesthetics, gave his thoughts on regenerative aesthetics and other recent skincare advancements.